Literature DB >> 11855151

Expression of mucosal cyto-chemokine mRNAs in patients with Helicobacter pylori infection.

S M Park1, J H Kim, Y H Hong, H R Jung, J Park, J G Kim, B C Yoo.   

Abstract

BACKGROUND: Helicobacter pylori-induced destruction of the gastroduodenal mucosal barrier is initiated with mucosal infiltration of inflammatory cells. Cytokines and chemokines have been suggested to play important roles in the migration and activation of these inflammatory cells into the mucosa. The present study aimed to investigate expression rates of cyto-chemokine mRNAs using gastric mucosal biopsy specimens.
METHODS: In 98 patients infected with Helicobacter pylori, mucosal mRNA expression rates of cytokines (IL-1 beta, IL-6, and IL-10), C-C chemokines (macrophage inflammatory protein 1 alpha (MIP-1 alpha), and macrophage inflammatory protein 1 beta (MIP-1 beta), monocyte chemotactic and activating factor (MCAF), regulated on activation, normal T cell expressed and presumably secreted (RANTES)) and C-X-C chemokines (IL-8 and growth regulated a (GRO-alpha)) were examined using reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: The expression rates of mRNA for IL-8, GRO-alpha, MIP-1 alpha and RANTES were significantly more increased in H. pylori-positive patients than in H. pylori-negative patients. However, the expressions of IL-1 beta, IL-6 and IL-10 mRNA were statistically not different between two groups. After eradication of H. pylori, expressions of mRNA for three cytokines (IL-1 beta, IL-6 and IL-10), four C-C chemokines (MIP-1 alpha, MIP-1 beta, MCAF and RANTES) and two C-X-C chemokines (IL-8 and GRO-alpha) were significantly decreased.
CONCLUSION: These results suggest that C-X-C chemokines and some C-C chemokines play important roles in H. pylori-associated peptic ulcer diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11855151      PMCID: PMC4578057          DOI: 10.3904/kjim.2001.16.4.230

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  18 in total

1.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

2.  Production of a conserved adhesin by the human gastroduodenal pathogen Helicobacter pylori.

Authors:  P Doig; J W Austin; M Kostrzynska; T J Trust
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

3.  Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro.

Authors:  S E Crowe; L Alvarez; M Dytoc; R H Hunt; M Muller; P Sherman; J Patel; Y Jin; P B Ernst
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

4.  Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients.

Authors:  P Gionchetti; D Vaira; M Campieri; J Holton; M Menegatti; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; M Miglioli
Journal:  Am J Gastroenterol       Date:  1994-06       Impact factor: 10.864

5.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

6.  Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.

Authors:  P M Goggin; J M Marrero; R T Spychal; P A Jackson; C M Corbishley; T C Northfield
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

7.  Inhibition of acid secretion from parietal cells by non-human-infecting Helicobacter species: a factor in colonization of gastric mucosa?

Authors:  M Vargas; A Lee; J G Fox; D R Cave
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection.

Authors:  J E Crabtree; P Peichl; J I Wyatt; U Stachl; I J Lindley
Journal:  Scand J Immunol       Date:  1993-01       Impact factor: 3.487

9.  Chemokines in the gastric mucosa in Helicobacter pylori infection.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; T Tanahashi; K Kashima; J Imanishi
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

10.  Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; S E Shires; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

View more
  4 in total

1.  Helicobacter pylori-stimulated interleukin-8 (IL-8) promotes cell proliferation through transactivation of epidermal growth factor receptor (EGFR) by disintegrin and metalloproteinase (ADAM) activation.

Authors:  Takashi Joh; Hiromi Kataoka; Satoshi Tanida; Katsushi Watanabe; Tadayuki Ohshima; Makoto Sasaki; Haruhisa Nakao; Hirotaka Ohhara; Shigeki Higashiyama; Makoto Itoh
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

2.  Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori.

Authors:  Takahiko Kudo; Hong Lu; Jeng Yih Wu; David Y Graham; Antonella Casola; Yoshio Yamaoka
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

3.  Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Hiroshi Nakano; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2008-10-29       Impact factor: 3.199

4.  Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis.

Authors:  Svetlana F Khaiboullina; Sayar Abdulkhakov; Alsu Khalikova; Dilyara Safina; Ekaterina V Martynova; Yuriy Davidyuk; Felix Khuzin; Rezeda Faizullina; Vincent C Lombardi; Georgi V Cherepnev; Albert A Rizvanov
Journal:  Front Microbiol       Date:  2016-12-15       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.